Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multicenter Efficacy, Safety and Dose-Effect Study of the Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable, Chronic Bronchitis

NCT00205647 is registered in ClinicalTrials.gov with Wake Forest University as lead sponsor.

NCT NCT00205647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00205647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multicenter Efficacy, Safety and Dose-Effect Study of the Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable, Chronic Bronchitis
Lead sponsor
Wake Forest University
Phase
Phase 2
Overall status
Completed
Start date
January 31, 1997
Completion date
March 31, 2000
Enrollment
240
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic bronchitis